Exfoliative dermatitis - Dermatitis Exfoliative
☆ AI Dermatology — Free Service
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Red (burning) Skin Syndrome – erythema kunye nesikali kumzimba wonke, yizona mpawu eziphambili ze Dermatitis Exfoliative (Exfoliative dermatitis).
relevance score : -100.0%
ReferencesErythroderma yimeko yolusu enqabileyo kodwa embi kakhulu. Nangona isizathu esikhulu singaziwa, ingabangelwa ukusabela kweziyobisi okanye umhlaza osisiseko. Umhlaza oqhelekileyo odityaniswe ne‑exfoliative dermatitis yi‑T‑cell lymphoma ye‑cutaneous, ongabonisa iimpawu kwiinyanga okanye iminyaka emva kokuba i‑erythroderma iqale. Ngokuqhelekileyo, kufunwa ukuhlala esibhedlele kunye nokuvavanywa kokuqala kunye nonyango. Izigulana ezine sifo esibangelwa ngamachiza ngokubanzi zineemeko ezilindelekileyo zexesha elide, nangona iimeko ezingenasizathu esicacileyo zikhuthaza ukuba kube ne‑relapse ephindaphindayo neyiyekisayo. I‑prognosis yamatyala anxulunyaniswa nomhlaza ixhomekeke kwindlela umhlaza oqhubeka ngayo.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Ibonisa ubukhulu becala ububomvu kunye nokugquma ngaphezulu kwe-90% yomzimba. Le meko luphawu olubonakalayo lwemiba eyahlukeneyo yezempilo efana ne-psoriasis, i-eczema, okanye impendulo kumayeza athile.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Isizathu esiqhelekileyo se-erythroderma kukugqithiswa kwesifo sesikhumba esingaphantsi, njenge-psoriasis, i-contact dermatitis, i-seborrheic dermatitis, i-lichen planus, i-pityriasis rubra pilaris, okanye ukuphendulwa kweziyobisi, ezifana nokusetyenziswa kwe-topical steroids. Imbonakalo yokuqala ayixhaphakanga kwaye idla ngokubonwa kwiimeko ze-T-cell lymphoma ye-cutaneous. Njengoko kubalulekile ukuhlukanisa i-cutaneous T-cell lymphoma, i-biopsy iyenziwa.